| 1. |
- Axelsson, Louise, 1990, et al.
(författare)
-
The Characteristics of Excellent Designers - Findings from an Interview Study with Swedish Innovators
- 2015
-
Ingår i: Proceedings of the International Conference on Engineering Design, ICED. - 2220-4334 .- 2220-4342. - 9781904670711 ; 80:DS 80-08, s. 131-140
-
Konferensbidrag (refereegranskat)abstract
- Some designers are more successful than others. They have the ability to repeatedly generate new and innovative solutions to challenging problems. In this paper, we refer to designers who possess this level of skill as “excellent designers”. It would seem interesting to identify the characteristics of such individuals in order to better understand why they succeed while ordinary designer do not. However, there have been few published studies of excellent designers, and these studies have focused on one or a few individuals.In this paper, we account for a study of a larger group (15) of excellent designers. The aims were first to identify their particular set of knowledge, experience, working practices and personal characteristics and then to use the findings to generate proposals for how employers and educator can nurture excellent designers.
|
|
| 2. |
- Kåberg, Martin, et al.
(författare)
-
High risk of non-alcoholic liver disease mortality in patients with chronic hepatitis C with illicit substance use disorder
- 2020
-
Ingår i: Scandinavian Journal of Gastroenterology. - : Taylor & Francis. - 0036-5521 .- 1502-7708. ; 55:5, s. 574-580
-
Tidskriftsartikel (refereegranskat)abstract
- Aims: Hepatitis C virus (HCV) is a slowly progressive disease, often transmitted among people who inject drugs (PWID). Mortality in PWID is high, with an overrepresentation of drug-related causes. This study investigated the risk of death in patients with chronic hepatitis C virus (HCV) infection with or without illicit substance use disorder (ISUD).Methods: Patients with HCV were identified using the Swedish National Patient Registry according to the International Classification of Diseases-10 (ICD-10) code B18.2, with ≤5 matched comparators from the general population. Patients with ≥2 physician visits with ICD-10 codes F11, F12, F14, F15, F16, or F19 were considered to have ISUD. The underlying cause of death was analyzed for alcoholic liver disease, non-alcoholic liver disease, liver cancer, drug-related and external causes, non-liver cancers, or other causes. Mortality risks were assessed using the standardized mortality ratio (SMR) with 95% CIs and Cox regression analyses for cause-specific hazard ratios.Results: In total, 38,186 patients with HCV were included, with 31% meeting the ISUD definition. Non-alcoholic liver disease SMRs in patients with and without ISUD were 123.2 (95% CI, 103.7-145.2) and 69.4 (95% CI, 63.8-75.3), respectively. The significant independent factors associated with non-alcoholic liver disease mortality were older age, being unmarried, male sex, and having ISUD.Conclusions: The relative risks for non-alcoholic liver disease mortality were elevated for patients with ISUD. Having ISUD was a significant independent factor for non-alcoholic liver disease. Thus, patients with HCV with ISUD should be given HCV treatment to reduce the risk for liver disease.
|
|
| 3. |
- Patricio, Joao, 1984, et al.
(författare)
-
Enabling industrial symbiosis collaborations between SMEs from a regional perspective
- 2018
-
Ingår i: Journal of Cleaner Production. - : Elsevier BV. - 0959-6526. ; 202, s. 1120-1130
-
Tidskriftsartikel (refereegranskat)abstract
- Small and Medium Enterprises make up the vast majority of the businesses within the European Union, and are consequently important contributors to local and regional well-being. Nevertheless, Small and Medium Enterprises face many challenges when it comes to fostering innovation and improving environmental performance as part of their day-to-day activities. In parallel, the global consumption of raw materials is increasing, which makes it necessary to define and establish strategies to reduce the amount of, and dependence on, raw material extraction and imports, whilst also improving the sustainability of SMEs. In this context it is essential to promote circular economy strategies, such as industrial symbiosis partnerships, where companies use the waste products of other industries as raw materials. To achieve this, there is a need to find enablers to support industrial symbiosis collaborations among SMEs. These could include regional developers and local authorities. The aims of this study are to investigate whether industrial symbiosis is already a common practice within SMEs in the Västra Götaland Region of Sweden, as well as identifying barriers and motivations for partnerships. For this purpose, case studies of two industries were carried out: beer production and mushroom farming. Information was collected using on-site visits and semi-structured interviews, and the key findings where combined with a literature review, then used to propose new industrial symbiosis opportunities. The results show that industrial symbiosis is already used by some of the beer and mushroom producers. Economic gains and better environmental performance were presented as the main motivations for the companies to be involved in these partnerships. Nevertheless, industrial symbiosis could be extended to also include those companies that do not yet share their waste, mostly due to a lack of time or knowledge. Consequently, the study suggests potential industrial symbiosis partnerships that could be implemented within a short period of time, and be used by the local authorities to help SMEs to achieve circularity of wastes. Future work considers the dissemination of the results among SMEs as well as apply the approach to other types of industries operating in the region to identify additional IS potential partnerships.
|
|
| 4. |
- Söderholm, Jonas, et al.
(författare)
-
ELEVATED RISK FOR LIVER RELATED MORTALITY IN CHRONIC HEPATITIS C PATIENTS BOTH WITH OR WITHOUT ILLICIT SUBSTANCE USE DISORDER : A NATION-WIDE REGISTER STUDY
- 2019
-
Ingår i: Hepatology. - : John Wiley & Sons. - 0270-9139 .- 1527-3350. ; 70:Suppl. 1, s. 366A-366A
-
Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
- Background: Hepatitis C is a slowly progressive disease mainly transmitted in people who inject drugs . This cohort has a high mortality from drug related causes, such as overdoses or external causes. We investigated the relative risk for liver related death in chronic hepatitis C (CHC) patients with or without illicit substance use disorders (SUD) .Methods: Patients with CHC were identified using the Swedish National Patient Registry (contains all inpatient, day surgery, and outpatient non-primary care visits) according to the International Classification of Diseases-10 (ICD-10) code B18.2. The baseline observation was set to the first CHC visit from 2001, and person-time continued until death, emigration or December 31, 2013, whichever came first. Patients with ≥2 non-primary care visits with ICD-10 codes F11, F12, F14, F15, F16, or F19 were considered to have illicit SUD . The underlying cause of death was obtained from the Cause of Death Register . A six months lag-period between CHC diagnosis and death was introduced to reduce surveillance bias. Non-alcoholic liver disease was defined using ICD-10 codes K71–K77, B15–B19, B94.2, R17-R18, I85 .0, I98 .2, and I98 .3 . The relative risk for death was determined using standardized mortality ratio (SMR) where the observed number of deaths was divided by the expected number of deaths taken from five comparators from the general population (matched for age/sex/place of residency) .Results: In total 38,186 patients with CHC were included in the study whereof 11,818 (31%) were considered to have illicit SUD . The CHC patients with SUD were younger (37 .7 vs . 46 .9 years) with a greater proportion of men (72% vs . 62%) than CHC patients without SUD . The SMRs for CHC patients with SUD were 10 .5, 33 .8, 18 .1, 123 .2, 61 .6, and 13 .2, for all-causes, liver cancer, alcoholic or non-alcoholic liver disease, drug-related, or external causes, respectively (Table 1) . The corresponding SMRs for CHC patients without SUD were 4 .1, 52 .8, 18 .0, 69 .4, 11 .2, and 4 .9, respectively (Table 1) .Conclusion: The relative risks for all investigated parameters were elevated for CHC patients whether they had illicit SUD or not . Furthermore, although the CHC patients with SUD had a high relative risk to die from both drug-related and external causes, the relative risk to die from non-alcoholic liver disease was also greatly elevated .
|
|
